Mechanical Circulatory Support (MCS) Devices Market: By Product Type (Ventricular Assist Devices, Left Ventricular Assist Devices (LVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), Artificial Heart, Extracorporeal Membrane Oxygenation, and Intra-Aortic Balloon Pumps), By End-User (Hospitals, Ambulatory Surgical Centers, and Specialty Cardiology Centers), and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Mechanical Circulatory Support (MCS) Devices Market Size was valued at USD 1.1 billion in 2021 and is poised to grow at a significant CAGR of 9.5% over 2022–2028. The aging population is anticipated to alter healthcare delivery and increase demand for remote mechanical circulatory support devices. According to Global Population Aging 2020 Report (United Nations, 2020), the aging population is expected to grow at an alarming rate. Around 727 million people worldwide will be 65 years of age or older in 2020, and the number of such patients is anticipated to double by 2050 and reach 1.5 billion. Thus, it is anticipated that each of these reasons will contribute to expanding the global market for mechanical circulatory support devices. As a result of the widespread increase in cardiovascular disorders, which mainly comprise heart failure problems, mechanical circulatory devices have become prospective treatment options for patients and are expected to fuel the market for mechanical circulatory support systems. Furthermore, according to the Centers for Disease Control and Prevention (CDC), the risk of heart failure will rise in 2020 due to specific risk factors such as coronary artery disease (CAD), heart attacks, diabetes, high blood pressure, and obesity. The prevalence of heart failure continues to rise over time with population aging, according to research from the American Heart Association 2020. Between 2013 and 2016, an estimated 6.2 million American adults under 20 experienced heart failure, compared to an estimated 5.7 million between 2009 and 2012. Continuous flow technology has helped ventricular assist devices (VAD) become more efficient and implantable. These devices are in more demand by offering lengthier support, allowing the market for mechanical circulatory support devices expands. The extensive use of mechanical circulatory support devices due to rising heart failure rates and a shortage of donors is anticipated to create enormous opportunities for the market's expansion internationally. Market players are applying the different market strategies such as mergers, acquisition and launching new products in the market. For instance, in February 2021, CARMAT received FDA approval to conduct an Early Feasibility Study (EFS) of its Total Artificial Heart in the US using BlueSync technology.

Recent Market Developments:

In December 2020, Abbott announced their FDA approval for updated labeling of the company’s HeartMate 3 heart pump so that it could be used readily in pediatric patients suffering from advanced refractory left ventricular heart failure. In Feb 2021, Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc. Transaction furthers Terumo’s efforts to improve patient outcomes and decrease healthcare costs through personalized predictive analytics and clinical decision support at the point of care

Global Mechanical Circulatory Support Mcs Devices Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Mechanical Circulatory Support (MCS) Devices Market Dynamics

The U.S. has about 500,000 new heart failure cases each year, contributing to the market expansion for mechanical circulatory support devices. Additionally, the rising incidence of heart failure has pushed up hospitalization rates, raising the cost of healthcare globally. The rise in cardiovascular disease incidence is boosting the market for mechanical circulatory support devices. According to the WHO, the leading cause of death worldwide each year is cardiovascular disease. The need for mechanical circulatory support devices is expanding due to technological developments in ventricular assist devices (VAD), such as continuous flow technology, which has improved implantability and efficiency, provided extended support, and enhanced the overall patient experience. Regulations about the safety of implanted devices and high treatment costs may limit market expansion.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Mechanical Circulatory Support Mcs Devices Market Segmentation

Product Type
  • Ventricular Assist Devices
  • Left Ventricular Assist Devices (LVAD)
  • Biventricular Ventricular Assist Devices (BIVAD)
  • Right Ventricular Assist Devices (RVAD)
  • Artificial Heart
  • Extracorporeal Membrane Oxygenation
  • Intra-Aortic Balloon Pumps
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Cardiology Centers
North America
  • US
  • Canada
  • Germany
  • Italy
  • France
  • Spain
  • UK
  • Rest of Europe
  • Japan
  • China
  • Australia & New Zealand
  • Rest of Asia-Pacific
Rest of World
  • Brazil
  • Saudi Arabia
  • Israel
  • Rest of RoW

Frequently Asked Questions

The Mechanical Circulatory Support (MCS) Devices Market is projected to expand at a CAGR of 9.5% during the forecast period.

Abiomed, Inc, Berlin Heart GmbH, Cardiac Assist, Inc, Cardio Bridge GmbH, Carmat SA

Asia-Pacific is the fastest-growing region for Mechanical Circulatory Support (MCS) Devices Market

  • Abbott Laboratories
  • Teleflex Incorporated
  • SynCardia Systems LLC
  • Jude Medical Inc
  • CorWave SA
  • Medtronic PLC
  • Terumo Heart, Inc.
  • NovaPump GmbH
  • Getinge AB
  • Balton Ltd.,
  • Meril Life Sciences Pvt. Ltd
  • Thoratec Corporation,